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Edited by Barry HalliwellAbstract Nucleobindin-1 (NUCB1) and nucleobindin-2
(NUCB2) are multifunctional proteins that interact with Ca2+,
nucleic acids and various regulatory proteins in diﬀerent signaling
pathways. So far, our understanding of the regulation of the bio-
logical functions of nucleobindins remains limited. In our prote-
ome-wide selection for downstream caspase substrates, both
NUCB1 and NUCB2 are found to be the downstream substrates
of caspases. We report here the detailed analyses of the cleavage
of nucleobindins by caspases. Signiﬁcantly, the caspase cleavage
sites are located exactly at one of the Ca2+-binding EF-hand mo-
tifs. Our results suggest that the functions of nucleobindins could
be modulated by caspase-mediated cleavage in apoptosis.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Nucleobindins are a class of EF-hand motif containing
Ca2+-binding proteins that have multiple functions. Two
nucleobindins have been identiﬁed so far, including NUCB1
(or CALNUC, NUC) and NUCB2 (or NEFA) [1,2]. These
two proteins are highly homologous with 62% amino acid se-
quence identity, although they are encoded by two separate
and unlinked gene loci. The most characteristic feature of
NUCB1 and NUCB2 is the presence of multiple functional
domains, including a signal peptide, a leucine/isoleucine rich
region, a putative nuclear localization signal, a DNA-binding
domain, two Ca2+-binding EF-hand motifs and a leucine zip-
per region (Fig. 1A).
NUCB1 was ﬁrst discovered to bind to the nucleosomal-lad-
dered DNA in SLE-prone MRL/lpr mice during apoptosis
[1,3]. Exogenous administration of the recombinant NUCB1
to MRL/n mice induced autoimmune phenomena and thymic
apoptosis, indicating that NUCB1 plays an important role in
inducing autoimmunity and apoptosis. Accumulating evidence
suggests that NUCB1 performs multiple functions through its
Ca2+-binding, DNA-binding and EF-hand-mediated interac-Abbreviations: CPT, camptothecin; NUCB1, nucleobindin-1; NUCB2,
nucleobindin-2; TNT, coupled in vitro transcription and translation
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highly abundant in the Golgi region of a large variety of tissues
and could play a key role in Ca2+ homeostasis in the cis-Golgi
network and cisternae [2,4,5]. Despite its presence in Golgi,
NUCB1 also possesses features of a transcription factor
through the basic amino acid-rich and the leucine zipper re-
gions [1]. In addition, NUCB1 interacts with multiple binding
partners, including Gai3, Gai2 and cyclooxygenases [6,7].
NUCB2 was originally identiﬁed in the common ALL cell line
KM3 [8]. Compared to NUCB1, NUCB2 is 40 residues shorter,
but also present in Golgi, with a Golgi retention motif at the N-
terminal leucine/isoleucine-rich region [9]. Despite their high
similarity on the structures of the functional domains, NUCB1
and NUCB2 are divergent at the N-terminal region, the leu-
cine-zipper, as well as the C-terminal sequences. NUCB2 was
found to interact with necdin and ARTS-1, both through the
EF-hand motifs [10,11]. Clinically, NUCB1 was implicated as
a tumor-associated antigen that appeared to be overexpressed
in many colon cancer tissues [12]. On the other hand, NUCB2
was implicated as an appetite suppressing protein that plays an
important role in regulating feeding behavior in rats [13].
Despite the great importance of NUCB1 and NUCB2 in
various signaling pathways, our understanding of the regula-
tion of their biological functions remains limited. In this re-
search letter, we show evidence that both NUCB1 and
NUCB2 are cleaved by caspases and their functions mediated
through the Ca2+-binding EF-hand motifs could be modulated
by caspase-catalyzed cleavage.2. Materials and methods
2.1. Generation of radiolabeled NUCB1 and NUCB2 proteins
The DNA templates coding the fragments of NUCB1 and NUCB2
were isolated from our previous caspase cleavage selections [14]. The
coding sequences for full-length NUCB1 and NUCB2 or their various
fragments were PCR ampliﬁed from total RNAs of human or zebraﬁsh
using gene speciﬁc primers. The PCR products were puriﬁed and used
as templates for a coupled in vitro transcription and translation (TNT)
reaction in the presence of [35S]-methionine. Expressed proteins were
used for proteolytic cleavage assays.2.2. In vitro proteolytic analysis of radiolabeled NUCB1 and NUCB2 by
caspases
An aliquot of TNT reaction mixture was incubated in a caspase
reaction buﬀer (50 mM HEPES, pH 7.4, 50 mM NaCl, 0.1% CHAPS,
10 mM EDTA, 5% glycerol and 10 mM DTT) at 37 C for 0.5–12 h
with 0.1–0.5 units of a caspase of interest (Biovision, Mountain View,
CA) or a caspase pre-inhibited with 10 lM of a corresponding tetra-
peptide inhibitor (Calbiochem, San Diego, CA). An aliquot of each
reaction mixture was loaded onto a 10% or 15% SDS–PAGE gel for
separation and the signals were detected by autoradiography.blished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic diagram of nucleobindins and cleavage analysis of
the selected fragments. (A) Schematic representation of the functional
domains on human NUCB1 and NUCB2. (B and C) In vitro cleavage
of the selected NUCB1 and NUCB2 fragments (FG) by caspase-3, -6,
-7 and -8. The radiolabeled protein fragments were generated by TNT.
(D) Sequences of the NUCB1 and NUCB2 fragments isolated from
diﬀerent caspase cleavage selections. (E) Cleavage site mapping using
radiolabeled NUCB1 fragments that cover diﬀerent regions. EF-H:
Ca2+-binding EF-hand motif; L-ZP: leucine-zipper motif; I: caspase-3
inhibitor Ac-DEVD-fmk. The black dot between two EF-hand motifs
represents an acidic region. The putative cleavage site is indicated by a
red arrow.
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at the N-terminus by caspases
To determine the cleavage of the N-terminal portion of NUCB1,
1 lg of a recombinant NUCB1 His · 6-tagged at the N-terminus (Gen-
Way Biotech, San Diego, CA) was subjected to cleavage assays by
incubation with 0.5 units of caspase-6 or -8 for 9 h. Alternatively, cas-
pase-6 or -8 were pre-inhibited with Z-VEID-fmk or Z-IETD-fmk,
respectively, for 30 min at 37 C prior to the addition of recombinant
NUCB1. Digestion reactions were resolved by SDS–PAGE gels, fol-
lowed by probing with an anti-His · 6 antibody (AnaSpec, San Jose,
CA).
2.4. Ex vivo proteolytic analysis of NUCB1 by caspases
HeLa S3 cells were grown to stationary phase in DMEMmedia sup-
plemented with 10% FBS. Cells were harvested and lysed as previously
described [14]. Caspase-catalyzed proteolysis of endogenous NUCB1
was performed by the addition of 0.5 units of a caspase of interest to
the whole cell extract with 25 lg of total protein. The reaction mixture
was incubated at 37 C at various time points in the presence or ab-
sence of a caspase inhibitor. Proteins in lysates were resolved by
SDS–PAGE and blots were probed with anti-NUCB1 polyclonal
antibody (Aviva Systems Biology, San Diego, CA) that recognizes a
region (EKKLLERLPEVEVPQHI) near the C-terminus of human
NUCB1.2.5. Cleavage of endogenous NUCB1 during apoptosis under
physiological conditions
The in vivo cleavage experiments were performed by the addition of
2 lM to 50 lM camptothecin (CPT) directly to MCF-7 or HeLa S3
cells, which were maintained in the appropriate media. For cleavage
inhibition assays, cells were pre-treated with 50 lM of a tetrapeptide
inhibitor for 3 h at 37 C before a 12 h induction of apoptosis by
2 lM CPT. The inhibitors used were Z-VAD-fmk (pancaspase inhibi-
tor), 5-[(S)-(+)-2-(methoxymethyl)pyrrolidino] sulfonylisatin (caspase-
3/-7 inhibitor), Z-DEVD-fmk (caspase-3 inhibitor), Z-VEID-fmk (cas-
pase-6 inhibitor), Z-IETD-fmk (caspase-8 inhibitor), Z-LEHD-fmk
(caspase-9 inhibitor) and Z-AEVD-fmk (caspase-10 inhibitor). For
time course experiments, MCF-7 or HeLa S3 cells were treated with
CPT up to 36 h. Cells were lysed using a lysis buﬀer on ice for 1 h
[14]. Crude extracts were cleared by centrifugation at 14,000 rpm for
20 min. Approximately 25 lg of lysate was loaded into each well, sep-
arated by SDS–PAGE, probed with C-terminal anti-NUCB1 and re-
probed with anti-b-actin as a loading control.3. Results and discussion
3.1. Caspase-mediated cleavage of NUCB1 and NUCB2 of
selected fragment and full-length proteins
To understand which proteins are speciﬁcally cleaved by a
caspase of interest during apoptosis, we carried out prote-
ome-wide selections for downstream substrates of diﬀerent cas-
pase family members [14]. Interestingly, NUCB1 was isolated
from the caspase-6 cleavage selection, whereas NUCB2 was
isolated from both the caspase-3 and -8 cleavage selections.
We ﬁrst examined whether the selected NUCB1 and NUCB2
fragments were indeed cleaved by various caspases using radi-
olabeled NUCB1 and NUCB2 fragments generated by TNT.
As shown in Fig. 1B and C, the selected NUCB1 and NUCB2
fragments were indeed cleaved by the caspases used in the
selections, respectively, although the cleavage of the selected
NUCB1 fragment was weak. Interestingly, both fragments
were also cleaved by other caspases. The selected NUCB1 frag-
ment could be cleaved by caspase-6 and -8, whereas the
NUCB2 fragment could be cleaved by caspase-3, -6 and -8
(Fig. 1B and C). In both cases, the cleavage was completely
abolished when the caspase was inactivated with an inhibitor.
We analyzed the sequences of the selected NUCB1 and
NUCB2 fragments and mapped their potential cleavage sites
(Fig. 1D). The NUCB1 fragment isolated from the selection
was from E186 to N281, which includes a region (233-
EELDGLDPNRFNPKTFFILHDINSDG-258) that contains
two potential caspase cleavage sites (underlined). The observed
cleavage by caspase-6 and -8 might occur at DGLDP or INS-
DG, although they are not the optimal cleavage sequences.
The cleavage site on NUCB1 was further mapped by a combi-
nation of diﬀerent approaches, including using a series of frag-
ments that contain only one potential cleavage site. Our results
indicate that only the fragment that contains DGLDP site
(FG174–460), but not any other fragments out of this region,
was cleaved by caspase-6 and -8 (Fig. 1E and data not shown).
Therefore, the cleavage most likely occurs at DGLDP. As for
NUCB2, six and ﬁve NUCB2 fragments were isolated from the
caspase-3 and -8 cleavage selections, respectively. These 11 se-
quences have diﬀerent lengths but all contain E175-L269 as the
common region (Fig. 1E). The same approaches were used to
map the cleavage site at 237-DGLDP-241 (data not shown).
To examine the cleavage at the full-length level, we ﬁrst
tested the cleavage of endogenous NUCB1 by adding puriﬁed
caspases to the HeLa S3 cell lysate. Fig. 2A illustrates that
Fig. 2. The caspase cleavage speciﬁcity and time course of full-length nucleobindins. (A) Ex vivo caspase cleavage speciﬁcity of endogenous full-
length NUCB1 from HeLa S3 lysate. (B) In vitro cleavage speciﬁcity of radiolabeled full-length NUCB1 generated by TNT. (C) In vitro cleavage
time course of radiolabeled full-length NUCB1 by caspase-6. (D) In vitro cleavage time course of radiolabeled full-length NUCB1 by caspase-8. (E)
In vitro caspase cleavage speciﬁcity of radiolabeled full-length NUCB2. (F) In vitro cleavage time course of radiolabeled full-length NUCB2 by
caspase-8. Endogenous NUCB1 was probed using an anti-NUCB1 antibody that recognizes its C-terminus. All radiolabeled NUCBs were detected
through autoradiography. Negative controls without using any caspase or with a pre-inhibited caspase were labeled as ‘‘-’’ and ‘‘Inh’’, respectively.
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caspase-7 and -9. Interestingly, a cleavage product with a
molecular weight of approximately 27 kDa was detected. The
observed proteolytic fragment was presumably from the C-ter-
minal area, since the blot was probed using an anti-NUCB1
antibody that recognizes a region near its C-terminus. We also
used radiolabeled full-length NUCB1 generated by TNT for
caspase cleavage analysis (Fig. 2B). The results were consistent
with that when endogenous NUCB1 was used. Fig. 2C and D
illustrates that the cleavage of radiolabeled NUCB1 by caspas-
es is fast, with a half-life of 3 and 1 h by caspase-6 and -8,
respectively.
Since we were not able to detect the expression of full-length
NUCB2 by using the commercial anti-NUCB2 antibodies
(Aviva Systems Biology and Abcam), full-length radiolabeled
NUCB2 generated by TNT was used as substrate for proteol-
ysis. As shown in Fig. 2E, full-length NUCB2 was cleaved by
caspase-3 and -8 that were used in the selections, with a half-
life around 0.5 h by caspase-8 (Fig. 2F). The size of the prote-
olytic product is also consistent with a cleavage at the mapped
site using the selected NUCB2 fragments. Intriguingly, full-
length NUCB2 thus generated was also cleaved by caspases-
6, -7, -9 and weakly by caspase-10. The cleavage patterns by
diﬀerent caspases were very similar, suggesting they have the
same cleavage sites.
3.2. NUCB1 was speciﬁcally cleaved during apoptosis under
physiological conditions
To examine the cleavage of nucleobindins under in vivo con-
ditions, we induced programmed cell death in diﬀerent cell lines
by CPT. Western blot analysis, using anti-NUCB1 against the
C-terminus, illustrates that NUCB1was cleaved during apopto-
sis as observed by the signiﬁcant decrease of the full-length in
MCF-7 cells and the appearance of a cleavage fragment in
HeLa S3 cells (Fig. 3A). The decrease of NUCB1 in both
MCF-7 and HeLa S3 cells was dependent on the concentrationof CPT that was used to induce apoptosis. Fig. 3B shows that
the cleavage of NUCB1 during apoptosis in MCF-7 cells is eﬃ-
cient and has a half-life around 9 h following a treatment with
2 lM CPT. Interestingly, no cleavage product was observed in
MCF-7 cells, suggesting that the cleavage products are further
degraded in vivo and therefore not detectable by anti-NUCB1
that recognizes the C-terminus. In contrast, a proteolytic
product was observed in HeLa S3 lysates (Fig. 3A, right panel),
presumably because various cell lines could behave diﬀerently
after the induction of apoptosis by CPT.
The in vivo cleavage of NUCB1 was caspase-speciﬁc and
completely inhibited by a caspase-8, -9 or -10 inhibitor
(Fig. 3C). Although our in vitro and ex vivo results indicate
that NUCB1 was digested eﬃciently by caspase-3, -6 and -8
(Fig. 2A and B), it is of great interest to examine which caspase
plays a major role in cleaving NUCB1 during apoptosis under
in vivo conditions. Since caspase-3 is not functional in MCF-7
cells [15], it is unlikely that caspase-3 is involved in the in vivo
cleavage of NUCB1. Interestingly, NUCB1 digestion still oc-
curred when the cells were pre-treated with a caspase-6 or cas-
pase-3/-7 inhibitor, suggesting these caspases are less likely to
play a major role in cleaving NUCB1. By combining the re-
sults of in vitro cleavage (Fig. 2A and B) and of in vivo inhi-
bition analyses (Fig. 3C), the observed in vivo cleavage of
NUCB1 in MCF-7 cells is likely mediated by caspase-8. How-
ever the role of other caspases cannot be completely ruled out.
It is worth mentioning that we were not able to detect the
cleavage of NUCB1 in cells that were not subjected to an
apoptotic stimuli, suggesting the cleavage of NUCB1 by the
basal caspase activity is below the detection limit.
3.3. The conservation of the caspase cleavage sites on
nucleobindins in diﬀerent species
We analyzed the conservation of the putative caspase
cleavage sites on both NUCB1 and NUCB2 in diﬀerent spe-
cies (Fig. 4A). Compared to human NUCB1, the NUCB1
Fig. 3. In vivo analysis of NUCB1 cleavage in MCF-7 and HeLa S3
cells and in vitro N-terminal digestion tracking of recombinant
NUCB1. (A) Cleavage of NUCB1 in MCF-7 (left panel) and HeLa
S3 (right panel) cells after a 12 h or 36 h induction with various
concentrations of CPT. (B) Western blot analysis of the time-
dependent cleavage of NUCB1 after the induction of apoptosis by
2 lM CPT in MCF-7 cells. (C) In vivo inhibition assay using diﬀerent
caspase inhibitors. Cells were pre-treated with 50 lM of various
inhibitors prior to the induction of apoptosis with 2 lM of CPT
(bottom panel). The inhibitors used were Z-VAD-fmk, 5-[(S)-(+)-2-
(methoxymethyl)pyrrolidino] sulfonylisatin, Z-VEID-fmk, Z-IETD-
fmk, Z-LEHD-fmk and Z-AEVD-fmk for pancaspase, caspase-3/-7,
caspase-6, -8, -9 and -10, respectively. NUCB1 was probed using an
anti-NUCB1 antibody that recognizes its C-terminus. (D) Tracking the
cleavage of the N-terminal portion of NUCB1. N-His · 6-NUCB1 was
digested with caspase-6 or -8 or caspases pre-inhibited with the
appropriate inhibitor. Blots were probed with an anti-His · 6 anti-
body.
Fig. 4. (A) Alignment of the selected, cleavage site-containing human
NUCB1 and NUCB2 fragments with the corresponding regions on
their orthologs from other species. The conserved caspase recognition
sites are highlighted in red. Non-conserved residues are marked in
yellow. The putative DQYD cleavage site on C. elegans NUCB is
underlined. (B) In vitro cleavage of zebraﬁsh NUCB2 full-length or
putative cleavage site-containing fragment by zebraﬁsh caspase-3
(ZCASP3) and by human caspase-3 (HCASP3). Ac-DEVD-CHO was
utilized as an inhibitor of ZCASP3.
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quence identities at 89%, 87% and 87%, respectively. The
cleavage site containing E233-G258 region is identical among
these four species. NUCB2 is also highly conserved among dif-
ferent mammalian species, with the identical DGLDP site.
These results suggest that the cleavage of NUCB1 and NUCB2
by caspases is highly conserved in diﬀerent species.It appears that the mapped DXXD cleavage site is also con-
served in other species, including in zebraﬁsh and Drosophila.
To test whether a nucleobindin protein from a non-mamma-
lian species could be indeed cleaved by its cognate caspase,
we synthesized the full-length zebraﬁsh NUCB2 (Z-NUCB2,
FL1–496) and the putative cleavage site-containing fragment
(FG151–295) and used them as substrates for the recombinant
zebraﬁsh caspase-3 [16]. Fig. 4B illustrates that both the full-
length and the fragment of Z-NUCB2 were eﬃciently and spe-
ciﬁcally cleaved by zebraﬁsh caspase-3. Interestingly, the cleav-
age was more eﬃcient by zebraﬁsh caspase-3 than by human
caspase-3, suggesting that Z-NUCB2 might be a physiological
caspase-3 substrate in zebraﬁsh. However, the evolutionary
conservation of the caspase cleavage sites on nucleobindins
does not necessarily correlate with the conservation of func-
tion. More studies should be performed to address this ques-
tion.
3.4. Implication of the regulation of Ca2+-signaling on NUCB1
and NUCB2 by caspase-mediated cleavage
As shown in Fig. 1A, multiple functional domains are pres-
ent on both NUCB1 and NUCB2 [1]. It appears that the multi-
ple functions of NUCB1 and NUCB2 are partitioned at the
ﬁrst and the second halves of the proteins. The ﬁrst half con-
tains a signal peptide, a leucine/isoleucine rich region and a
putative nuclear targeting signal. Therefore, this half of the
nucleobindins is important for their subcellular localization.
It has been reported that a NUCB2 mutant lacking the N-ter-
minal leucine/isoleucine-rich region failed to be retained in the
Golgi, whereas the deletion of all the other domains or regions
had no eﬀect [9]. The second half of nucleobindins contains
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which are critical in sensing the Ca2+ signal, interacting with
a number of binding partners and associating with DNA.
The caspase cleavage sites we identiﬁed on NUCB1 and
NUCB2 are within the region of residues 235–255. In both
nucleobindins, such cleavage sites are exactly located at the
beginning of the ﬁrst Ca2+-binding EF-hand motif that is just
downstream of the putative bipartite nuclear targeting signal.
It has been demonstrated that the EF-hand motifs on NUCB1
and NUCB2 are very important for their binding with Ca2+
and also interaction with a number of other binding partners,
including Gai3, Gai2, cyclooxygenases, necdin and ARTS-1.
Therefore, it is likely that such functions could be aﬀected by
caspase-mediated cleavage. However, which speciﬁc functions
of EF-hand motifs are disrupted remain to be addressed.
The caspase-mediated cleavage will presumably truncate the
nucleobindins into at least two pieces. Such cleavage will
decouple the functional domains on the ﬁrst and the second
halves that are otherwise well integrated. After the cleavage,
the second half is less likely to be retained in Golgi apparatus
or translocated to nucleus, due to the removal of the N-termi-
nal Golgi retention domain and the nuclear targeting signal. In
light of this hypothesis, we traced the fate of the N-terminal
portion of NUCB1 by using an N-terminal His · 6-tagged
NUCB1. It was found that the N-terminal tagged NUCB1
was rapidly degraded in vivo. Therefore, we addressed the
question by incubating a recombinant NUCB1 His · 6-tagged
at the N-terminus with puriﬁed caspase-6 or -8 (Fig. 3D). The
result shows that a major fragment is produced from such a
cleavage, with a size consistent with digestion at the mapped
site. Due to the rapid degradation of the N-terminal tagged
NUCB1 in mammalian cells, the physiological role of the N-
terminal region should be addressed using antibodies that spe-
ciﬁcally recognize the N-terminus of the endogenous protein or
using caspase-resistant mutants. Future work will be directed
to investigate the role of the N-terminus, the regulation of
the biological functions of NUCB1 and NUCB2 by Ca2+ sig-
nals and by caspases under physiological conditions.
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